AU2016285483B2 - Inhibitors of indoleamine 2,3-dioxygenase - Google Patents
Inhibitors of indoleamine 2,3-dioxygenase Download PDFInfo
- Publication number
- AU2016285483B2 AU2016285483B2 AU2016285483A AU2016285483A AU2016285483B2 AU 2016285483 B2 AU2016285483 B2 AU 2016285483B2 AU 2016285483 A AU2016285483 A AU 2016285483A AU 2016285483 A AU2016285483 A AU 2016285483A AU 2016285483 B2 AU2016285483 B2 AU 2016285483B2
- Authority
- AU
- Australia
- Prior art keywords
- mmol
- compound
- oxadiazol
- bromo
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *c(c(Br)c1)ccc1NC(*NO)c1n[o]nc1NCCNC(c1c(B(O)OCC2)c2ccc1)=O Chemical compound *c(c(Br)c1)ccc1NC(*NO)c1n[o]nc1NCCNC(c1c(B(O)OCC2)c2ccc1)=O 0.000 description 3
- ZGFSKLMZAWHQCE-UHFFFAOYSA-N CCCNC(c1c(B(O)OC=C2)c2ccc1)=O Chemical compound CCCNC(c1c(B(O)OC=C2)c2ccc1)=O ZGFSKLMZAWHQCE-UHFFFAOYSA-N 0.000 description 1
- XVKQWLOZHJZZLX-UHFFFAOYSA-N CN(C(c1n[o]nc1NCCNC(c1c(B(O)OCC2)c2ccc1)=O)Nc(cc1[Br]=C)ccc1F)O Chemical compound CN(C(c1n[o]nc1NCCNC(c1c(B(O)OCC2)c2ccc1)=O)Nc(cc1[Br]=C)ccc1F)O XVKQWLOZHJZZLX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187937P | 2015-07-02 | 2015-07-02 | |
| US62/187,937 | 2015-07-02 | ||
| PCT/IB2016/053947 WO2017002078A1 (en) | 2015-07-02 | 2016-06-30 | Inhibitors of indoleamine 2,3-dioxygenase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016285483A1 AU2016285483A1 (en) | 2018-01-04 |
| AU2016285483B2 true AU2016285483B2 (en) | 2018-07-19 |
Family
ID=56363880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016285483A Ceased AU2016285483B2 (en) | 2015-07-02 | 2016-06-30 | Inhibitors of indoleamine 2,3-dioxygenase |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10239894B2 (enExample) |
| EP (1) | EP3317287B1 (enExample) |
| JP (1) | JP6654208B2 (enExample) |
| KR (1) | KR20180022988A (enExample) |
| CN (1) | CN107709338A (enExample) |
| AU (1) | AU2016285483B2 (enExample) |
| BR (1) | BR112017028456A2 (enExample) |
| CA (1) | CA2990335A1 (enExample) |
| ES (1) | ES2752455T3 (enExample) |
| RU (1) | RU2018101431A (enExample) |
| WO (1) | WO2017002078A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108530444B (zh) * | 2018-06-11 | 2021-08-24 | 药康众拓(江苏)医药科技有限公司 | 一种新型nampt和ido双重抑制剂及其制备方法和医药用途 |
| LT3873903T (lt) | 2018-10-31 | 2024-05-10 | Gilead Sciences, Inc. | Pakeistieji 6-azabenzimidazolo junginiai, kaip hpk1 inhibitoriai |
| CN117105933A (zh) | 2018-10-31 | 2023-11-24 | 吉利德科学公司 | 具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物 |
| TWI826690B (zh) | 2019-05-23 | 2023-12-21 | 美商基利科學股份有限公司 | 經取代之烯吲哚酮化物及其用途 |
| CN110156629A (zh) * | 2019-05-30 | 2019-08-23 | 广州药本君安医药科技股份有限公司 | 丙卡巴肼的合成方法 |
| EP4052705A1 (en) | 2021-03-05 | 2022-09-07 | Universität Basel Vizerektorat Forschung | Compositions for the treatment of ebv associated diseases or conditions |
| JP2024510949A (ja) | 2021-03-05 | 2024-03-12 | ウニヴェルシタット・バーゼル | Ｅｂｖ関連疾患又は状態の治療用組成物 |
| WO2025119216A1 (zh) * | 2023-12-04 | 2025-06-12 | 珠海联邦制药股份有限公司 | 硼酸类β-内酰胺酶抑制剂及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006122150A1 (en) * | 2005-05-10 | 2006-11-16 | Incyte Corporation | Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| WO2010005958A2 (en) * | 2008-07-08 | 2010-01-14 | Incyte Corporation | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| WO2014066834A1 (en) * | 2012-10-26 | 2014-05-01 | The University Of Chicago | Synergistic combination of immunologic inhibitors for the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB427857A (en) | 1934-08-02 | 1935-05-01 | Newsum Sons & Company Ltd H | A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames |
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| EP1378509A4 (en) | 2001-03-19 | 2009-03-25 | Ono Pharmaceutical Co | DRUGS WITH TRIAZASPIRO ç5.5] UNDECANDERIVATES AS ACTIVE SUBSTANCE |
| RU2008112221A (ru) | 2005-08-31 | 2009-10-10 | Селджин Корпорейшн (Us) | Соединения ряда изоиндолимидов, их композиции и способы применения |
| AU2011329485A1 (en) * | 2010-11-18 | 2013-04-18 | Glaxo Group Limited | Compounds |
-
2016
- 2016-06-30 RU RU2018101431A patent/RU2018101431A/ru not_active Application Discontinuation
- 2016-06-30 CN CN201680039221.7A patent/CN107709338A/zh active Pending
- 2016-06-30 US US15/578,861 patent/US10239894B2/en not_active Expired - Fee Related
- 2016-06-30 CA CA2990335A patent/CA2990335A1/en not_active Abandoned
- 2016-06-30 BR BR112017028456A patent/BR112017028456A2/pt not_active Application Discontinuation
- 2016-06-30 EP EP16735943.9A patent/EP3317287B1/en active Active
- 2016-06-30 WO PCT/IB2016/053947 patent/WO2017002078A1/en not_active Ceased
- 2016-06-30 JP JP2017568056A patent/JP6654208B2/ja not_active Expired - Fee Related
- 2016-06-30 ES ES16735943T patent/ES2752455T3/es active Active
- 2016-06-30 AU AU2016285483A patent/AU2016285483B2/en not_active Ceased
- 2016-06-30 KR KR1020187003254A patent/KR20180022988A/ko not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006122150A1 (en) * | 2005-05-10 | 2006-11-16 | Incyte Corporation | Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| WO2010005958A2 (en) * | 2008-07-08 | 2010-01-14 | Incyte Corporation | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| WO2014066834A1 (en) * | 2012-10-26 | 2014-05-01 | The University Of Chicago | Synergistic combination of immunologic inhibitors for the treatment of cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2752455T3 (es) | 2020-04-06 |
| CA2990335A1 (en) | 2017-01-05 |
| RU2018101431A (ru) | 2019-08-05 |
| BR112017028456A2 (pt) | 2018-08-28 |
| CN107709338A (zh) | 2018-02-16 |
| JP2018521056A (ja) | 2018-08-02 |
| US20180298035A1 (en) | 2018-10-18 |
| JP6654208B2 (ja) | 2020-02-26 |
| EP3317287A1 (en) | 2018-05-09 |
| EP3317287B1 (en) | 2019-07-31 |
| KR20180022988A (ko) | 2018-03-06 |
| AU2016285483A1 (en) | 2018-01-04 |
| WO2017002078A1 (en) | 2017-01-05 |
| US10239894B2 (en) | 2019-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016285483B2 (en) | Inhibitors of indoleamine 2,3-dioxygenase | |
| US11274102B2 (en) | Compounds useful in HIV therapy | |
| US9029391B2 (en) | Isoquinoline compounds and methods for treating HIV | |
| EP3886987B1 (en) | Compounds useful in hiv therapy | |
| JP2018532727A (ja) | インドールアミン２，３−ジオキシゲナーゼのモジュレーター | |
| US20220117993A1 (en) | Compounds Useful in HIV Therapy | |
| US20240051972A1 (en) | Compounds Useful in HIV Therapy | |
| US10583140B2 (en) | Ingenol analogs, pharmaceutical compositions and methods of use thereof | |
| US20180273579A1 (en) | Compounds with hiv maturation inhibitory activity | |
| JP2022543319A (ja) | Ｈｉｖ治療に有用な化合物 | |
| HK40052462A (en) | Compounds useful in hiv therapy | |
| HK40052462B (en) | Compounds useful in hiv therapy | |
| EP3328876A1 (en) | Betuin derivatives for preventing or treating hiv infections | |
| EP3328875A1 (en) | Betuin derivatives for preventing or treating hiv infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |